A Phase 2 Study of Vx-950 in Combination With Peginterferon Alfa-2a (Pegasys)With & Without Ribavirin (Copegus) in ..... Grant uri icon

Overview

total award amount

  • 70778.25

direct costs

  • 56622.20

sponsor award id

  • VX05-950-104

Background

Time

date/time interval

  • June 1, 2006 - April 18, 2010

Identity

DSR Number

  • 07103158
  • 08013164
  • 08031056
  • 08042964

PeopleSoft Contract Number

  • 00060279

local award id

  • 00060279